—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY《发育医学与儿童神经病学》
月刊 - 英国
  • DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY《发育医学与儿童神经病学》
  • SCIE外文期刊
  • 期发文量19
  • 国人占比0.00%
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:2区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:0
    环比增速:0%
  • 期刊信息

  • 研究方向:医学-PEDIATRICS 儿科;CLINICAL NEUROLOGY 临床神经病学
  • 国际刊号:ISSN0012-1622;EISSN1469-8749
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:http://mc.manuscriptcentral.com/dmcn
  • 电子邮箱:
  • 期刊官网:https://onlinelibrary.wiley.com/journal/14698749
  • 作者指南:
  • 出版商网址:http://www.wiley.com/WileyCDA/
  • 出版地址:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
  • 期刊简介:DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY《发育医学与儿童神经病学》(月刊). Developmental Medicine & Child Neurology (DMCN) is a multidisciplinary journal that has defined the fields of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.

  • 万维提示





  • 1、投稿方式:在线投稿

    2期刊网址:

    https://onlinelibrary.wiley.com/journal/14698749

    3投稿网址:http://mc.manuscriptcentral.com/dmcn

    4、官网邮箱:dmcn@editorialoffice.co.uk(编辑部)

    5期刊刊期:月刊,一年出版12

    2021年8月12日星期

                                     

     

    投稿须知【官网信息】

     

    Author Guidelines

    Developmental Medicine & Child Neurology

    Updated June 2021

    All papers should be submitted online at http://mc.manuscriptcentral.com/dmcn. Please email the editorial office with any queries about the process (dmcn@editorialoffice.co.uk).

    Papers published in Developmental Medicine & Child Neurology (DMCN) are freely available online from 12 months after publication. Authors who wish to make their papers freely accessible immediately upon publication may use Wiley’s pay-to-publish service, Open Access. (See 2 Copyright below).

    Note to NIH Grantees

    Pursuant to NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate

    Open access policy in Research Excellence Framework (REF) 2021

    In order to be eligible for submission to the next REF, DMCN is compliant with the REF Open Access policy which states authors’ outputs must be deposited in an institutional or subject repository after an embargo period of 12 months. For further information about the policy, see https://www.ref.ac.uk/media/1228/open_access_summary__v1_0.pdf

    Quick check submission table

    Checklists

    Submissions must be accompanied by the appropriate checklist. Read the ‘Reporting guidelines’ section below for more information.

    Disclosure of interests

    The DOI form must be completed and submitted to the Editorial Office with your manuscript.

    Title

    Should be direct and cover the main focus of the paper.

    Authors

    First names, middle initials, and surnames. Up to 10 authors on the title page.

    Affiliations

    Department, institution, city, and country. Include at least one affiliation per author.

    Corresponding author

    Postal and e-mail address for corresponding author.

    Abbreviations

    List abbreviations that are not commonly used. Avoid using abbreviations of two letters wherever possible.

    Abstract

    Original articles, systematic reviews, and scoping reviews should follow the structure: AIM, METHOD, RESULTS, INTERPRETATION up to 200 words.

    Invited reviews, clinical practice guidelines, and case series should have unstructured abstracts up to 150 words.

    Short title

    Original articles only. Provide a shortened title, up to 45 characters.

    What this paper adds

    Max 12 words each. The bullet points should contain only new results offered by the paper.

    Up to 5 points for original articles, systematic reviews, scoping reviews, and clinical practice guidelines.

    Up to 2 points for other article types.

    Main text

    Manuscripts should be concise and clear.

    Acknowledgements

    List sources of funding or support and any conflict of interest.

    Supporting information

    Cite in the main text and list all supporting files after the main text.

    References

    Vancouver style is used. Original articles, invited reviews, and clinical practice guidelines should have a max of 30; systematic and scoping reviews may have more; max 15 for case series; max 5 for commentaries, editorials, and letters to the editor.

    Tables/Figures

    Max 4 per paper. Keep descriptions brief and explain abbreviations in table description.

    ……

    更多详情:

    https://onlinelibrary.wiley.com/page/journal/14698749/homepage/forauthors.html






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码